Ethereum (ETH) has entered a decisive phase after a sharp sell-off erased much of its recent gains and pushed the price toward the closely watched $2,200 level.Ethereum (ETH) has entered a decisive phase after a sharp sell-off erased much of its recent gains and pushed the price toward the closely watched $2,200 level.

Ethereum Faces High-Stakes Moment at $2,200 as Whale Longs Clash With Bearish Flow Data

2026/02/03 10:00
3 min read

Ethereum (ETH) has entered a decisive phase after a sharp sell-off erased much of its recent gains and pushed the price toward the closely watched $2,200 level. The move followed repeated failures to break above the $2,500–$2,550 zone, triggering liquidations.

Related Reading: Crypto Hacks Explode: $370 Million Stolen In January Alone: Researchers

With large holders taking opposing positions and on-chain data flashing caution, ETH is now at a point where both downside risk and rebound potential remain firmly in play.

Ethereum Price Structure Weakens as $2,200 Comes Into Focus

Ethereum (ETH) has fallen more than 20% from recent highs, briefly trading below $2,220 before stabilizing.

The drop pushed ETH below the $2,300–$2,400 range and under key short-term moving averages, shifting near-term control toward sellers. Technical data shows a developing bearish trend line around $2,400–$2,420, an area that would need to be reclaimed to ease downside pressure.

The $2,200 zone is now acting as the main support. A sustained break below this level could expose deeper downside toward $2,050 or psychological $2,000 mark. Momentum indicators remain cautious, with the hourly RSI below 50 and MACD still aligned with bearish momentum, suggesting buyers have yet to regain control.

Exchange Inflows and Liquidations Signal Distribution Risk

On-chain data has added to concerns. Exchange inflows surged ahead of the breakdown, with roughly 600,000 ETH moving onto major exchanges in a single day, including a sharp spike into Binance. Such inflows are often associated with selling, hedging, or risk reduction rather than accumulation.

At the same time, derivatives markets saw heavy stress. ETH-related liquidations reached about $280 million over 24 hours, surpassing Bitcoin and confirming that long positions were crowded near recent highs.

The unwind’s speed suggests structural weakness, as spot demand failed to absorb forced selling once support levels gave way.

Whale Longs Add a Bullish Counterweight

Despite bearish flow data, whale activity tells a more mixed story. According to on-chain analysts, dormant wallets reactivated after five years and posted over 45,000 ETH as collateral to open a large coin-margined long, borrowing roughly $100 million.

This move highlights growing divergence at current levels, with some institutions deleveraging while certain large holders add exposure.

Related Reading: Is The Bitcoin Bottom In? CMT Reveals What Traders Need To See Now

This clash between whale longs and bearish exchange flows shows the uncertainty around $2,200. A rebound above $2,420 could shift momentum back toward buyers, while failure to hold current support may confirm that distribution pressure remains dominant.

Cover image from ChatGPT, ETHUSD on Tradingview

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29